PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9224727-6 1997 Other parameters associated with loss of Mn-SOD such as increase in carbonyl proteins and decrease of sulfhydryl content were also significantly enhanced by AZT in Tat mice. Zidovudine 157-160 superoxide dismutase 2, mitochondrial Mus musculus 41-47 25260898-0 2014 Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction. Zidovudine 111-114 superoxide dismutase 2, mitochondrial Mus musculus 44-74 35631648-7 2022 Zidovudine/lamivudine-treated mice had elevated malondialdehyde levels (oxidative stress marker) compared to other groups and lower mRNA levels of manganese superoxide dismutase and peroxisome proliferator-activated receptor gamma coactivator 1-alpha in the placenta compared to tenofovir/emtricitabine-treated mice. Zidovudine 0-10 superoxide dismutase 2, mitochondrial Mus musculus 147-177 25260898-0 2014 Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction. Zidovudine 111-114 superoxide dismutase 2, mitochondrial Mus musculus 76-81 19398959-10 2009 AZT worsens cardiac dysfunction and increases mitochondrial H(2)O(2) in SOD2(+/-) KO. Zidovudine 0-3 superoxide dismutase 2, mitochondrial Mus musculus 72-76 19398959-11 2009 Conversely, both SOD2-OX and mCAT TGs prevent or attenuate AZT-induced cardiac oxidative stress and LV dysfunction. Zidovudine 59-62 superoxide dismutase 2, mitochondrial Mus musculus 17-21